You are here

Article info

Article menu
Download PDFPDF
Acute coronary syndromes
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA

Authors

  1. Correspondence to Dr Jonas Oldgren, Uppsala Clinical Research Center, Uppsala University Hospital, S-751 85 Uppsala, Sweden; jonas.oldgren{at}ucr.uu.se
View Full Text

Citation

Oldgren J, Wernroth L, Stenestrand U, et al
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA
Heart 2010;96:1451-1457.

Publication history

  • Accepted June 3, 2010
  • First published July 23, 2010.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.